26,27-dimethylene-1.alpha.,25-dihydroxyvitamin D.sub.2 and 26,27

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

552653, C07C40100

Patent

active

053977750

ABSTRACT:
Vitamin D.sub.2 analogs in which a cyclopentane ring is introduced onto the 25-carbon of the side chain of 1.alpha.,25-dihydroxyvitamin D.sub.2 and its 24-epimer. The compounds are characterized by a marked intestinal calcium transport activity while exhibiting much lower activity than 1.alpha.,25-dihydroxyvitamin D.sub.3 in their ability to mobilize calcium from bone. Because of their preferential calcemic activity, these compounds would be useful for the treatment of diseases where bone formation is desired, such as osteoporosis.

REFERENCES:
patent: 4588716 (1986-05-01), DeLuca et al.
patent: 4769181 (1988-09-01), DeLuca et al.
patent: 4851401 (1989-07-01), DeLuca et al.
patent: 4973584 (1990-11-01), DeLuca et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

26,27-dimethylene-1.alpha.,25-dihydroxyvitamin D.sub.2 and 26,27 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 26,27-dimethylene-1.alpha.,25-dihydroxyvitamin D.sub.2 and 26,27, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 26,27-dimethylene-1.alpha.,25-dihydroxyvitamin D.sub.2 and 26,27 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-713843

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.